Ritonavir is a protease inhibitor primarily used in combination therapy to manage HIV/AIDS by blocking the viral replication cycle. Pharmaceutical laboratories utilize this category of reference standards… Read more






















![Chemical structure of 2-Isopropyl-4-[(N-methylamino)methyl]thiazole Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F908591-25-3-2-Isopropyl-4-N-methylaminomethylthiazole-Hydrochloride.png&w=3840&q=75)

![Chemical structure of 2S,3S,5S-5-Amino-2-[N-[[(5-thiozolyl)methoxy]carbonyl]amino]-1,6-diphenyl-3-hydroxyhexane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F144164-11-4-2S3S5S-5-Amino-2-N-5-thiozolylmethoxycarbonylamino-16-diphenyl-3-hydroxyhexane.png&w=3840&q=75)



amino]-2-hydroxy-1-(phenylmethyl)propyl]-Carbamic Acid Phenylmethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F159005-61-5-1S2R-3-4-Aminophenylsulfonyl2-methylpropylamino-2-hydroxy-1-phenylmethylpropyl-Carbamic-Acid-Phenylmethyl-Ester.png&w=3840&q=75)

![Chemical structure of Carbamic acid, [(1R,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F220887-41-2-Carbamic-acid-1R3S4S-4-amino-3-hydroxy-5-phenyl-1-phenylmethylpentyl-11-dimethylethyl-ester.png&w=3840&q=75)













![Chemical structure of N-[(1S,3S,4R)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1414933-91-7-N-1S3S4R-4-Amino-3-hydroxy-5-phenyl-1-phenylmethylpentyl-11-dimethylethyl-ester.png&w=3840&q=75)
![Chemical structure of N-[[(4-Nitrophenyl)methoxy]carbonyl]-D-valine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F864531-87-3-N-4-Nitrophenylmethoxycarbonyl-D-valine.png&w=3840&q=75)
![Chemical structure of N-[[N-Methyl-N-[(2-isopropyl-1,1,1,3,3,3-d6]-4-thiazolyl)methyl)amino]carbonyl-L-valine Carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1331906-73-0-N-N-Methyl-N-2-isopropyl-111333-d6-4-thiazolylmethylaminocarbonyl-L-valine-Carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of N-[[N-Methyl-N-[(2-isopropyl-1,1,1,3,3,3-d6]-4-thiazolyl)methyl)amino]carbonyl-L-valine Methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1331897-89-2-N-N-Methyl-N-2-isopropyl-111333-d6-4-thiazolylmethylaminocarbonyl-L-valine-Methyl-Ester.png&w=3840&q=75)
![Chemical structure of N-Methyl-N-[(2-isopropyl-1,1,1,3,3,3-d6]-4-thiazolyl)methyl)amine, Hydrochloride Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1246818-86-9-N-Methyl-N-2-isopropyl-111333-d6-4-thiazolylmethylamine-Hydrochloride-Salt.png&w=3840&q=75)

Ritonavir is a protease inhibitor primarily used in combination therapy to manage HIV/AIDS by blocking the viral replication cycle. Pharmaceutical laboratories utilize this category of reference standards to support rigorous quality control and analytical testing of Ritonavir and its associated compounds. The collection includes pharmacopeial and non-pharmacopeial impurities, which are vital for accurate impurity profiling, allowing for the precise identification and quantification of process-related and degradation products. Additionally, stable isotope labelled compounds are available to serve as internal standards in liquid chromatography-mass spectrometry, ensuring reliable results during method validation and stability studies. By providing well-characterized materials for structural analysis and identity verification, these products assist in maintaining high standards of pharmaceutical development, regulatory compliance, and overall drug consistency throughout the product lifecycle.